The inexplicable and relentless rise of cancer drug prices
from The Washington Post
The $10,000-a-month cancer drug has become the new normal, to the dismay of physicians and patients who increasingly face the burden of financial toxicity. A pair of new studies illustrates just how recently that pricing model has come into vogue and pulls back the curtain on the strange market forces that push prices steadily higher in the years after the treatments are launched.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063